Cellumed Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Cellumed Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Cellumed Co. Ltd (049180) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-294.63 Million ≈ $-199.67K USD) by net assets (₩16.52 Billion ≈ $11.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Cellumed Co. Ltd (2011–2024)

Cash flow conversion efficiency of Cellumed Co. Ltd from 2011 to 2024. This chart illustrates how Cellumed Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 049180 live share price for real-time trading data and today's change.

Cellumed Co. Ltd Cash Flow Conversion Ratio Explained

Cellumed Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Cellumed Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cellumed Co. Ltd ranked by their cash flow conversion efficiency. Also see market value of Cellumed Co. Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
PanGen Biotech Inc KQ:222110	-0.122x
Insung Information Co. Ltd KQ:033230	-0.098x
Ihlas Haber Ajansi AS IS:IHAAS	-0.228x
Batavia Prosperindo Finance JK:BPFI	-0.183x
STG International Ltd TA:STG	0.095x
Eastern Star Real Estate Public Company Limited BK:ESTAR	-0.003x
JERSEY OIL+GAS PLC LS-01 F:TPC1	N/A
Avonmore Capital & Management Services Limited NSE:AVONMORE	0.002x

Annual Cash Flow Conversion Efficiency for Cellumed Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cellumed Co. Ltd from 2011 to 2024. Review Cellumed Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩8.78 Billion ≈ $5.95 Million	₩-418.53 Million ≈ $-283.63K	-0.048x	+79.65%
2023-12-31	₩23.02 Billion ≈ $15.60 Million	₩-5.40 Billion ≈ $-3.66 Million	-0.234x	-48.97%
2022-12-31	₩53.94 Billion ≈ $36.56 Million	₩-8.49 Billion ≈ $-5.75 Million	-0.157x	+30.01%
2021-12-31	₩47.99 Billion ≈ $32.52 Million	₩-10.79 Billion ≈ $-7.31 Million	-0.225x	-108.37%
2020-12-31	₩28.10 Billion ≈ $19.04 Million	₩-3.03 Billion ≈ $-2.05 Million	-0.108x	-218.21%
2019-12-31	₩5.18 Billion ≈ $3.51 Million	₩472.90 Million ≈ $320.48K	0.091x	+217.96%
2018-12-31	₩23.02 Billion ≈ $15.60 Million	₩-1.78 Billion ≈ $-1.21 Million	-0.077x	+43.15%
2017-12-31	₩37.28 Billion ≈ $25.27 Million	₩-5.07 Billion ≈ $-3.44 Million	-0.136x	-48.08%
2016-12-31	₩46.56 Billion ≈ $31.55 Million	₩-4.28 Billion ≈ $-2.90 Million	-0.092x	+17.86%
2015-12-31	₩41.27 Billion ≈ $27.97 Million	₩-4.62 Billion ≈ $-3.13 Million	-0.112x	+15.92%
2014-12-31	₩44.01 Billion ≈ $29.83 Million	₩-5.86 Billion ≈ $-3.97 Million	-0.133x	-1907.43%
2013-12-31	₩49.20 Billion ≈ $33.34 Million	₩362.28 Million ≈ $245.51K	0.007x	-15.57%
2012-12-31	₩48.75 Billion ≈ $33.04 Million	₩425.13 Million ≈ $288.10K	0.009x	-69.52%
2011-12-31	₩31.75 Billion ≈ $21.52 Million	₩908.37 Million ≈ $615.59K	0.029x	--

About Cellumed Co. Ltd

KQ:049180 Korea Medical Instruments & Supplies

Market Cap

$37.57 Million

₩55.44 Billion KRW

Market Cap Rank

#22745 Global

#1495 in Korea

Share Price

₩1009.00

Change (1 day)

-9.10%

52-Week Range

₩660.00 - ₩2570.00

All Time High

₩36700.00